Fever News and Research

RSS

Journal of Rheumatology publishes positive results from Cimzia Phase III trial in RA

UCB announced today results from a post hoc analysis of the RAPID 1 study published in the Journal of Rheumatology. The results suggest moderate to severe rheumatoid arthritis patients treated with Cimzia, the only approved PEGylated anti-TNF, together with methotrexate, achieved a rapid response associated with improved long-term outcomes one year after treatment began.

11 May 2011

Study confirms LcS-fermented milk reduces fever linked with acute norovirus gastroenteritis

The Laboratory Department for Probiotics Research at the Juntendo University Graduate School of Medicine studied supplementation of probiotic fermented milk containing Lactobacillus casei strain Shirota in elderly individuals living at a nursing home and confirmed reduced fever associated with acute norovirus gastroenteritis.

10 May 2011

Simple ultrasound examination may avoid complex tests for children with urinary tract infection

For infants and young children with urinary tract infection seen in the ER, a simple ultrasound examination may avoid the need for more complex x-ray tests, reports a study in the May issue of The Pediatric Infectious Disease Journal.

10 May 2011

Millennium presents VELCADE Phase III trial data in multiple myeloma at IMW meeting

Millennium: The Takeda Oncology Company today reported the presentation of results of a randomized Phase III trial that investigated the effect of consolidation with single-agent VELCADE for Injection in newly diagnosed multiple myeloma patients after autologous stem cell transplant.

7 May 2011

FDA approves Afinitor for treatment of progressive neuroendocrine tumors in the pancreas

On Thursday, the U.S. Food and Drug Administration approved Afinitor (everolimus) to treat patients with progressive neuroendocrine tumors located in the pancreas (PNET) that cannot be removed by surgery or that have spread to other parts of the body (metastatic).

7 May 2011

Filipino children with KD at greater risk for inflammation of heart blood vessels

While children of all ethnicities can contract Kawasaki disease (KD), a study led by researchers at the Kawasaki Disease Research Center at the University of California, San Diego and Rady Children's Hospital-San Diego finds that Filipino children with KD are at a higher risk for inflammation of the blood vessels of the heart than those of other Asian and non-Asian backgrounds.

7 May 2011

Researchers find temperature-sensing protein in immune cells

Researchers at The Scripps Research Institute have found a temperature-sensing protein within immune cells that, when tripped, allows calcium to pour in and activate an immune response.

7 May 2011

Millennium presents three studies in relapsed multiple myeloma at IMW meeting

Millennium: The Takeda Oncology Company today reported results from three studies in relapsed multiple myeloma. Two of the studies examined the use of VELCADE for Injection; the third study presents clinical data on MLN9708, the first investigational oral proteasome inhibitor.

6 May 2011

FDA approves Novartis' Afinitor tablets for pancreatic NET treatment

Novartis Pharmaceuticals Corporation announced today that the US Food and Drug Administration approved Afinitor tablets for the treatment of progressive neuroendocrine tumors of pancreatic origin in patients with unresectable, locally advanced or metastatic disease.

6 May 2011

Fecal transplant procedures performed at Sinai Hospital

Sudhir Dutta, M.D., head of the Division of Gastroenterology at Sinai Hospital, performed fecal transplant procedures for two patients with severe clostridium difficile (C. difficile) colitis that did not respond to routine antibiotic and other treatments. C. difficile causes symptoms ranging from mild diarrhea to more serious, sometimes life threatening colon inflammation.

5 May 2011

Lead investigator to discuss growing impact of AFib on US health care costs and resources

Two studies to be presented this week address the often-overlooked costs associated with atrial fibrillation, the most common form of cardiac arrhythmia.

5 May 2011

Merial, GenVec extend deal to develop and commercialize foot-and-mouth disease vaccine

GenVec, Inc. today announced that it has entered into a second agreement with Merial, the animal health division of sanofi-aventis.

3 May 2011

NanoViricides' FluCide drug candidate greatly reduces lung viral load in animals

NanoViricides, Inc. reports that post-infection treatment with its optimized FluCide drug candidates achieved 1,000-fold reduction in the levels of infectious virus in the lungs of animals with a lethal level of influenza virus infection.

3 May 2011

South Australian man succumbs to Murray Valley Encephalitis

A 27-year-old South Australian Riverland man has succumbed to Murray Valley Encephalitis (MVE) – a viral disease that is carried by mosquitoes. According to SA Health's chief medical officer Paddy Phillips, the man had been receiving hospital care for MVE since March.

3 May 2011

Hospitals can implement preventive measures to reduce measles outbreak

The U.S. measles vaccination program has been successful in eliminating endemic measles in the United States; yet this success has provided challenges that require ongoing vigilance for the rapid identification and response to measles cases in health care settings.

2 May 2011

Study explores link between infants' daily growth and sleep

Science is finally confirming what grandma knew all along: infants wake up taller right after they sleep.

2 May 2011

Antiviral Drugs Advisory Committee recommends FDA to approve telaprevir for hepatitis C

Vertex Pharmaceuticals Incorporated announced that the Antiviral Drugs Advisory Committee to the U.S. Food and Drug Administration voted unanimously to recommend FDA approval of telaprevir for people with genotype 1 chronic hepatitis C.

29 Apr 2011

UIC receives federal contract to develop antibiotics against three bacterial infections

Researchers at the University of Illinois at Chicago's Center for Pharmaceutical Biotechnology have been awarded a federal contract for up to $13.8 million to develop antibiotics to treat anthrax, tularemia and plague.

28 Apr 2011

Researchers begin approved drugs screening for clinical use against rare diseases

Researchers have begun screening the first definitive collection of thousands of approved drugs for clinical use against rare and neglected diseases. They are hunting for additional uses of the drugs hoping to find off-label therapies, for some of the 6,000 rare diseases that afflict 25 million Americans.

28 Apr 2011

Clinical study: Plant extract can fight effectively against hay fever

Fighting hay fever with a plant extract - this works, as was shown in a clinical study conducted by researchers of the Center of Allergy & Environment of Helmholtz Zentrum München and Technische Universität München.

27 Apr 2011

Fever News and Research

Journal of Rheumatology publishes positive results from Cimzia Phase III trial in RA

Study confirms LcS-fermented milk reduces fever linked with acute norovirus gastroenteritis

Simple ultrasound examination may avoid complex tests for children with urinary tract infection

Millennium presents VELCADE Phase III trial data in multiple myeloma at IMW meeting

FDA approves Afinitor for treatment of progressive neuroendocrine tumors in the pancreas

Filipino children with KD at greater risk for inflammation of heart blood vessels

Researchers find temperature-sensing protein in immune cells

Millennium presents three studies in relapsed multiple myeloma at IMW meeting

FDA approves Novartis' Afinitor tablets for pancreatic NET treatment

Fecal transplant procedures performed at Sinai Hospital

Lead investigator to discuss growing impact of AFib on US health care costs and resources

Merial, GenVec extend deal to develop and commercialize foot-and-mouth disease vaccine

NanoViricides' FluCide drug candidate greatly reduces lung viral load in animals

South Australian man succumbs to Murray Valley Encephalitis

Hospitals can implement preventive measures to reduce measles outbreak

Study explores link between infants' daily growth and sleep

Antiviral Drugs Advisory Committee recommends FDA to approve telaprevir for hepatitis C

UIC receives federal contract to develop antibiotics against three bacterial infections

Researchers begin approved drugs screening for clinical use against rare diseases

Clinical study: Plant extract can fight effectively against hay fever

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News